• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Qiagen N.V. Common Shares (NY:QGEN)

33.04 -0.47 (-1.40%)
Official Closing Price Updated: 7:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,657,804
Open 33.44
Bid (Size) 32.43 (100)
Ask (Size) 33.63 (1,000)
Prev. Close 33.51
Today's Range 32.92 - 33.44
52wk Range 32.92 - 57.81
Shares Outstanding 227,985,334
Dividend Yield 0.76%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Qiagen (QGEN) Q1 2026 Earnings Transcript ↗
May 07, 2026
Qiagen (QGEN) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
May 07, 2026
From QIAGEN N.V.
Via Business Wire

Performance

YTD
-26.9%
-26.9%
1 Month
-19.9%
-19.9%
3 Month
-35.2%
-35.2%
6 Month
-24.2%
-24.2%
1 Year
-21.6%
-21.6%

More News

Read More
QIAGEN N.V. (NYSE:QGEN) Q1 Earnings Miss Estimates, Guidance Cut Sinks Stock ↗
May 06, 2026
Via Chartmill
Topics Earnings
News headline image
QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm
May 06, 2026
From Schall Law
Via GlobeNewswire
News headline image
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
Via Benzinga
News headline image
QIAGEN Reports Full Results for Q1 2026
May 06, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
April 27, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
April 16, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
April 14, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results
March 20, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
March 19, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
March 10, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery
February 19, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars
February 04, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026
February 03, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN Appoints Mark Stevenson to Supervisory Board
January 26, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast
January 19, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth
January 12, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN N.V. (NYSE:QGEN) Passes the "Caviar Cruise" Quality Stock Screen ↗
December 27, 2025
Via Chartmill
News headline image
Wall Street Rallies as Cooling Inflation Offsets Labor Market Fog and "Great Data Gap"
December 19, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
December 18, 2025
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025
November 10, 2025
From QIAGEN N.V.
Via Business Wire
News headline image
Qiagen (QGEN) Q3 2025 Earnings Call Transcript ↗
November 05, 2025
Via The Motley Fool
Topics Earnings World Trade
News headline image
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase
November 04, 2025
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions
November 04, 2025
From QIAGEN N.V.
Via Business Wire

Frequently Asked Questions

Is Qiagen N.V. Common Shares publicly traded?
Yes, Qiagen N.V. Common Shares is publicly traded.
What exchange does Qiagen N.V. Common Shares trade on?
Qiagen N.V. Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Qiagen N.V. Common Shares?
The ticker symbol for Qiagen N.V. Common Shares is QGEN on the New York Stock Exchange
What is the current price of Qiagen N.V. Common Shares?
The current price of Qiagen N.V. Common Shares is 33.04
When was Qiagen N.V. Common Shares last traded?
The last trade of Qiagen N.V. Common Shares was at 05/08/26 07:00 PM ET
What is the market capitalization of Qiagen N.V. Common Shares?
The market capitalization of Qiagen N.V. Common Shares is 7.53B
How many shares of Qiagen N.V. Common Shares are outstanding?
Qiagen N.V. Common Shares has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap